1 Ocak 2011 Dergi makalesi Açık Erişim

Torul, Hilal; Tamer, Ugur

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
    <subfield code="o">oai:zenodo.org:21903</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">A validated HPLC-UV method was developed for the determination of R(-), S(+)-atenolol and R(-), S(+)-propranolol in pharmaceutical formulations. The proposed method required no elaborate sample preparation and was found to be selective, linear, and repeatable within the established ranges. Atenolol and propranolol isomers were separated using a Chirex 3022 (S) column with the mobile phases hexane-dichloromethane-methanol-trifluoroacetic acid (35+35+5+0.25, v/v/v/v) and hexane-dichloromethane-ethanol-trifluoroacetic acid (55+40+5+0.25, v/v/v/v), respectively. The LOD values of R(-) and S(+)-atenolol were 12.3 and 9.86 mu g/mL, respectively, and 0.61 and 0.89 mu g/mL, respectively, for R(-) and S(+)-propranolol. Retention times of R(-)-propranolol and S(+)-propranolol were 12.4 and 14.3 min, respectively, and 29.06 and 32.71 min, respectively, for (R)-atenolol and (S)-atenolol. The proposed method was applied to the determination of enantiomers in pharmaceutical formulations, and no interference from any excipients was found.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.81043/aperta.21902</subfield>
    <subfield code="n">doi</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Torul, Hilal</subfield>
    <subfield code="u">Gazi Univ, Dept Analyt Chem, Fac Pharm, TR-06330 Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:375ac3a323cf79b7bad752c2df31ef91</subfield>
    <subfield code="s">173</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/21903/files/bib-05f28da7-0a81-477b-8163-002d99acf1f5.txt</subfield>
  </datafield>
  <controlfield tag="005">20210315105510.0</controlfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2011-01-01</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.81043/aperta.21903</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Determination of Enantiomers of Atenolol and Propranolol in Pharmaceutical Formulations by HPLC</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="v">94</subfield>
    <subfield code="p">JOURNAL OF AOAC INTERNATIONAL</subfield>
    <subfield code="c">833-838</subfield>
    <subfield code="n">3</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Tamer, Ugur</subfield>
    <subfield code="u">Gazi Univ, Dept Analyt Chem, Fac Pharm, TR-06330 Ankara, Turkey</subfield>
  </datafield>
  <controlfield tag="001">21903</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
</record>